| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |